We would like to invite you to our 3nd Annual Detroit Research Roundtable Saturday, April 27, 2019 from 10:00 am to 12:00 pm. This event will feature experts from the Michael J. Fox Foundation for Parkinson’s Research sharing the latest updates on research progress in pursuit of a cure, as well as, local doctors.
This is complimentary to all guest. Light refreshments will be provided. Friends, guests and family are welcome.
Click here to RSVP now.
Kuldip D. Dave joined the Foundation in 2010. As Director, Research Programs, Kuldip stays closely linked to the Parkinson’s community in order to develop an aggressive and innovative agenda for accelerating research and drug development for Parkinson’s disease. This ensures that MJFF priorities reflect and best serve the ultimate needs of patients. Kuldip regularly meets with academic and industry scientists around the world to identify promising proposals to support, providing troubleshooting and ongoing management of projects as they go forward. He supports the Foundation’s priority interest in alpha-synuclein, an important protein linked genetically and pathologically to Parkinson’s disease. He also oversees the emerging targets portfolio to identify and validate novel targets for PD.
Dr. Dave earned an undergraduate degree in biology from Rutgers University and a PhD in Pharmacology & Physiology from the MCP-Hahnemann University. His thesis work focused on serotonergic regulation of motor function and learning and memory. He completed his postdoctoral fellowship at a small biotechnology firm Adolor Corporation investigating opioid-receptor regulation of pain and inflammation pathways. Kuldip went on to work for the pharmaceutical company Wyeth managing programs within the Women’s Health Department focusing on the hormonal regulation of mood and sexual disorders. He brings this broad CNS drug-discovery experience and knowledge to the Foundation to help bring new treatments to people with Parkinson’s. Kuldip is proud to work for the foundation and is passionate about the mission to finding the cure for Parkinson’s disease.
Daniel Leventhal, MD, PhD is an Assistant Professor of Neurology in the Movement Disorders division. His primary clinical duties are at the VA Ann Arbor Healthcare System, where he co-directs the Deep Brain Stimulation program for Movement Disorders. His practice there focuses on the treatment of Parkinson Disease, tremor disorders, dystonia, and related syndromes.
Dr. Leventhal completed his undergraduate degree in Physics at The College of William and Mary in Virginia in 1995, and a combined MD/PhD program (PhD in Biomedical Engineering) at Case Western Reserve University in 2004. He then pursued medical internship and Neurology residency at the University of Michigan (completed in 2008), followed by a combined Movement Disorders and postdoctoral research fellowship at Michigan. In 2012, he joined the Neurology faculty at Michigan, and joined the VA as a staff Neurologist in 2015.
He has also directs a basic science laboratory at the University of Michigan. His research interests lie primarily in understanding the brain circuit abnormalities that contribute to the clinical manifestations of Parkinson Disease and related disorders. His laboratory uses advanced in vivo neuronal recordings and manipulations in rats and mice as they learn and perform complex behaviors. The doctor is a member of the American Academy of Neurology, Movement Disorders Society, American Neurological Association, and Society for the Neural Control of Movement.